Chardan Capital Has Lowered Expectations for CRISPR Therapeutics (NASDAQ:CRSP) Stock Price
otakuyassine3@gmail.com CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its target price reduced by Chardan Capital from...
NASDAQ:CRSP
CRISPR Therapeutics (NASDAQ:CRSP) Given “Buy” Rating at HC Wainwright
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities...
Research Analysts Set Expectations for CRSP Q3 Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Equities research analysts at Brookline Capital Management...
CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 0.1% – Here’s What Happened
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price fell 0.1% on Tuesday ....
CRISPR Therapeutics (NASDAQ:CRSP) Hits New 12-Month Low – Time to Sell?
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price hit a new 52-week low...